Literature DB >> 20359301

Antibody validation.

Jennifer Bordeaux1, Allison Welsh, Seema Agarwal, Elizabeth Killiam, Maria Baquero, Jason Hanna, Valsamo Anagnostou, David Rimm.   

Abstract

Antibodies are among the most frequently used tools in basic science research and in clinical assays, but there are no universally accepted guidelines or standardized methods for determining the validity of these reagents. Furthermore, for commercially available antibodies, it is clear that what is on the label does not necessarily correspond to what is in the tube. To validate an antibody, it must be shown to be specific, selective, and reproducible in the context for which it is to be used. In this review, we highlight the common pitfalls when working with antibodies, common practices for validating antibodies, and levels of commercial antibody validation for seven vendors. Finally, we share our algorithm for antibody validation for immunohistochemistry and quantitative immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359301      PMCID: PMC3891910          DOI: 10.2144/000113382

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  42 in total

Review 1.  A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory.

Authors:  E D Hsi
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

Review 2.  Surface plasmon resonance-based immunoassays.

Authors:  W M Mullett; E P Lai; J M Yeung
Journal:  Methods       Date:  2000-09       Impact factor: 3.608

3.  A novel quality control slide for quantitative immunohistochemistry testing.

Authors:  Seshi R Sompuram; Vani Kodela; Keming Zhang; Halasya Ramanathan; Gail Radcliffe; Peter Falb; Steven A Bogen
Journal:  J Histochem Cytochem       Date:  2002-11       Impact factor: 2.479

Review 4.  Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

Authors:  James W Mandell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results.

Authors:  Anthony S Y Leong
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-03

6.  Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing.

Authors:  E Kay; A O'Grady; J M Morgan; S Wozniak; B Jasani
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

7.  Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry.

Authors:  Clifford B Saper; Paul E Sawchenko
Journal:  J Comp Neurol       Date:  2003-10-13       Impact factor: 3.215

8.  Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system.

Authors:  T W Jacobs; A M Gown; H Yaziji; M J Barnes; S J Schnitt
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

9.  High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.

Authors:  B Zafrani; M H Aubriot; E Mouret; P De Crémoux; Y De Rycke; A Nicolas; E Boudou; A Vincent-Salomon; H Magdelénat; X Sastre-Garau
Journal:  Histopathology       Date:  2000-12       Impact factor: 5.087

10.  Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Authors:  Matthew C Franklin; Kendall D Carey; Felix F Vajdos; Daniel J Leahy; Abraham M de Vos; Mark X Sliwkowski
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

View more
  238 in total

1.  Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

Authors:  Liang Guo; Sandy Eldridge; Mike Furniss; Jodie Mussio; Myrtle Davis
Journal:  Curr Protoc Chem Biol       Date:  2015-09-01

2.  Antibody anarchy: A call to order.

Authors:  Monya Baker
Journal:  Nature       Date:  2015-11-26       Impact factor: 49.962

Review 3.  Analysis of In Vitro Aptamer Selection Parameters.

Authors:  Maureen McKeague; Erin M McConnell; Jose Cruz-Toledo; Elyse D Bernard; Amanda Pach; Emily Mastronardi; Xueru Zhang; Michael Beking; Tariq Francis; Amanda Giamberardino; Ashley Cabecinha; Annamaria Ruscito; Rocio Aranda-Rodriguez; Michel Dumontier; Maria C DeRosa
Journal:  J Mol Evol       Date:  2015-11-03       Impact factor: 2.395

4.  Multiplexed ion beam imaging of human breast tumors.

Authors:  Michael Angelo; Sean C Bendall; Rachel Finck; Matthew B Hale; Chuck Hitzman; Alexander D Borowsky; Richard M Levenson; John B Lowe; Scot D Liu; Shuchun Zhao; Yasodha Natkunam; Garry P Nolan
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

5.  Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule.

Authors:  Michael Dobosz; Ute Haupt; Werner Scheuer
Journal:  MAbs       Date:  2016-09-23       Impact factor: 5.857

6.  Epitope mapping of commercial antibodies that detect myocilin.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Michael P Fautsch; Raquel L Lieberman
Journal:  Exp Eye Res       Date:  2018-05-09       Impact factor: 3.467

7.  Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell Function.

Authors:  Claire E Repellin; Priya Ganesan; Javier F Alcudia; Haritha K Duggireddy Lakshmireddy; Puja Patel; Lucia Beviglia; Harold S Javitz; Lidia Sambucetti; Parijat Bhatnagar
Journal:  Adv Biosyst       Date:  2019-11-29

8.  Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.

Authors:  Veronique M Neumeister; Valsamo Anagnostou; Summar Siddiqui; Allison Michal England; Elizabeth R Zarrella; Maria Vassilakopoulou; Fabio Parisi; Yuval Kluger; David G Hicks; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2012-10-22       Impact factor: 13.506

9.  An improved single-chain Fab platform for efficient display and recombinant expression.

Authors:  James T Koerber; Michael J Hornsby; James A Wells
Journal:  J Mol Biol       Date:  2014-12-03       Impact factor: 5.469

10.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.